<p>In vitro mitochondrial-targeted antioxidant peptide induces apoptosis in cancer cells</p>

Abstract

In other studies, investigating rat liver mitochondria, the uptake of KRSH may reach 80% compared with that for mitoquinone. Therefore, KRSH was designed as a superior peptide antioxidant and a mitochondria-targeting anticancer agent.